aurora kinase inhibitor PF-03814735
Term · Oncology and biomedicine · MLC-T-ONC-011307
An aurora kinase inhibitor with potential antineoplastic activity. PF-03814735 binds to and inhibits aurora kinases, serine-threonine kinases that play essential roles in mitotic checkpoint control during mitosis. Inhibition of aurora kinases may result in an inhibition of cellular division and proliferation in tumor cells that overexpress aurora kinases.
| Identifier | MLC-T-ONC-011307 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011307",
"term": "aurora kinase inhibitor PF-03814735",
"field": "Oncology and biomedicine",
"definition": "An aurora kinase inhibitor with potential antineoplastic activity. PF-03814735 binds to and inhibits aurora kinases, serine-threonine kinases that play essential roles in mitotic checkpoint control during mitosis. Inhibition of aurora kinases may result in an inhibition of cellular division and proliferation in tumor cells that overexpress aurora kinases.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/aurora-kinase-inhibitor-pf-03814735/"
}
Record 2,628 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.